EPISODE · Feb 18, 2026 · 57 MIN
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
from Hematologic Oncology Update
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.CME information and select publications here.
Embed this episode
NOW PLAYING
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
0:00
57:58
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 57 minutes long.
When was this Hematologic Oncology Update episode published?
This episode was published on February 18, 2026.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!